سبحان دارو

دسبحان | Stocks - Tehran Stock Exchange (TSE)

داروهای شیمیایی و گیاهی

Sector:

Market Type:

Status:

Last Price: 21,730 1.94

Close Price: 21,570

	2026/05/13 Fiscal Year 2025/12/2112 Month	2025/03/15 Fiscal Year 2024/12/2012 Month	2024/05/19 Fiscal Year 2024/03/1912 Month
Net Profit to Sales	17.76	21.59	24.22
Gross Profit to Sales	20.13	21.59	28.84
Operating Margin	40.31	31.6	38.26
Gross Profit to Sales	46.98	38.73	42.09
Net Profit to Gross Profit	37.8	55.74	57.53
Return on Assets (ROA)	11.23	8.61	16.94
Return on Capital (%)	53.31	42.52	90.08
Return on Equity (ROE)	30.17	28.76	46.52
Working Capital Return	31.42	37.62	49.94
Fixed Asset Return	72.54	51.07	127.93
Loan Benefit Assessment	2.69	3.34	2.75
Current Ratio	1.75	1.39	1.67
Quick Ratio	1.42	1.06	1.18
Liquidity Ratio	0.04	0.01	0.01
Net Working Capital	16,965,473	7,707,972	9,615,091
Current Assets Ratio	0.84	0.82	0.85
Inventory Turnover	159.59	299.9	197.34
Receivables Collection Period	340.59	521.41	278.39
Inventory to Working Capital	0.44	0.83	0.74
Working Capital Turnover	1.77	1.74	2.06
Fixed Asset Turnover	4.09	2.37	5.28
Total Asset Turnover	0.63	0.4	0.7
Debt Ratio	0.63	0.7	0.64
Debt to Equity	1.69	2.34	1.75
Long-Term Debt to Equity	0.4	0.38	0.35
Current Debt to Equity	1.29	1.96	1.4
Equity Ratio	37.21	29.95	36.42
Debt Coverage Ratio	1.04	1.5	1.04

At a Glance